↓ Skip to main content

Dove Medical Press

Article Metrics

Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis

Overview of attention for article published in Neuropsychiatric Disease and Treatment, April 2011
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
42 Mendeley
Title
Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis
Published in
Neuropsychiatric Disease and Treatment, April 2011
DOI 10.2147/ndt.s10469
Pubmed ID
Authors

Keith Hayes

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
South Africa 1 2%
Unknown 40 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 29%
Student > Master 7 17%
Researcher 4 10%
Student > Postgraduate 3 7%
Student > Bachelor 3 7%
Other 7 17%
Unknown 6 14%
Readers by discipline Count As %
Medicine and Dentistry 16 38%
Neuroscience 5 12%
Psychology 4 10%
Nursing and Health Professions 3 7%
Sports and Recreations 2 5%
Other 4 10%
Unknown 8 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2014.
All research outputs
#5,609,698
of 17,365,229 outputs
Outputs from Neuropsychiatric Disease and Treatment
#844
of 2,663 outputs
Outputs of similar age
#102,340
of 277,378 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#27
of 93 outputs
Altmetric has tracked 17,365,229 research outputs across all sources so far. This one is in the 47th percentile – i.e., 47% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,663 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,378 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.